DCT Tracker update: decentralised clinical trials to reach new peak
Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.

Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine